Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Assembly Biosciences (ASMB) Return on Equity: 2016-2025

Historic Return on Equity for Assembly Biosciences (ASMB) over the last 8 years, with Sep 2025 value amounting to -0.37%.

  • Assembly Biosciences' Return on Equity rose 91.00% to -0.37% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.37%, marking a year-over-year increase of 91.00%. This contributed to the annual value of -1.08% for FY2024, which is 9.00% down from last year.
  • Latest data reveals that Assembly Biosciences reported Return on Equity of -0.37% as of Q3 2025, which was up 77.72% from -1.66% recorded in Q2 2025.
  • In the past 5 years, Assembly Biosciences' Return on Equity ranged from a high of -0.26% in Q1 2021 and a low of -2.38% during Q3 2023.
  • For the 3-year period, Assembly Biosciences' Return on Equity averaged around -1.46%, with its median value being -1.45% (2024).
  • In the last 5 years, Assembly Biosciences' Return on Equity tumbled by 43bps in 2021 and then surged by 111bps in 2024.
  • Quarterly analysis of 4 years shows Assembly Biosciences' Return on Equity stood at -0.67% in 2021, then reached -1.53% in 2023, then climbed by 24bps to -1.28% in 2024, then surged by 91bps to -0.37% in 2025.
  • Its Return on Equity stands at -0.37% for Q3 2025, versus -1.66% for Q2 2025 and -1.25% for Q1 2025.